Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Alaunos Therapeutics | ZIOP - Laba Operasional
Keuangan
Harga Saham
USD
Aktiva
USD 1.88M
Kas Dan Setara
USD 354K
Biaya Penjualan
USD 0
Aset Lancar
USD 970K
Kewajiban Lancar
USD 595K
UTANG
USD 10.99M
EBIT
USD -1.01M
EBITDA
USD -21.02M
Karyawan
1
Eps Laba Per Saham
USD -0.52
Modal Dan Cadangan
USD 1.29M
Laba Kotor Pada Penjualan
USD -1.13M
Beban Bunga Utang
USD 1.07M
Modal Pinjaman
USD 4.47M
Kapitalisasi Pasar
USD 25M
Batas Pemasukan
USD -1.01M
Biaya Operasional
USD 1.01M
Laba Operasional
USD -1.01M
Modal Saham Biasa
USD 2.38M
Laba Sebelum Pajak
USD -7.84M
Pendapatan Penjualan
USD 2K
Beban Penjualan Dan Administrasi
USD 447K
Kreditur Perdagangan
USD 400K
Debitur Perdagangan
USD 2K
Laba Operasional
Perubahan
Tanggal
Alaunos Therapeutics
USD -1.01M
175K
2026-03
Amgen
USD 4.61B
777M
2026-06
AstraZeneca
USD 3.16B
3.95B
2026-06
Baxter International
USD 276M
210M
2026-06
Biogen
USD -243.8M
758.1M
2026-06
Bioline Rx
USD -3M
382K
2026-03
Bristol-Myers Squibb
USD 299M
3.07B
2026-06
Celltrion
KRW 12.9B
822.77M
2026-03
Corcept Therapeutics
USD 41.3M
90.9M
2026-06
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Curis
USD -11.52M
3.64M
2026-03
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Dianthus Therapeutics
USD -46.53M
23.01M
2026-03
Divis Laboratories Ltd
INR 11.29B
3.15B
2026-06
Gilead Sciences
USD 3.85B
1.17B
2026-06
GlaxoSmithKline
GBP 2.6B
312M
2026-06
Incyte
USD 700.4M
376.22M
2026-06
Intrexon
USD -60.84M
26.62M
2024-06
Ionis Pharmaceuticals
USD -102.29M
15.71M
2026-06
J&J
USD 7.48B
860M
2026-06
Kangmei Pharma
CNY -10.94M
15.75M
2026-03
Karyopharm Therapeutics
USD -26.76M
8.92M
2026-03
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Merck
USD 840M
2.72B
2026-06
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
Novartis
USD 4.75B
515M
2026-06
Organigram Holdings
CAD -9.79M
10.33M
2026-03
Ovoca Bio
EUR -173K
990K
2025-12
Pfizer
USD 667M
4.32B
2026-06
Pharma Mar
EUR -1.4M
2.03M
2026-06
PTC Therapeutics
USD 45.89M
127.51M
2026-03
Qiagen NV
USD 141.4M
24.77M
2026-06
Regeneron Pharmaceuticals
USD 1.42B
675.7M
2026-06
Roche Holding
CHF 11.46B
1.91B
2026-06
Sangamo BioSciences
USD -33.51M
12.77M
2024-06
Sartorius
EUR 164M
3.3M
2026-06
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
TG Therapeutics
USD 21.67M
13.12M
2026-06
Tilray
USD -20.01M
9.34M
2025-09
Verastem
USD -44.9M
3.42M
2026-03
Zealand Pharma A/S
-539M
168.05M
2026-03
Zz Pientze Pharmaceu
CNY 362.83M
474.98M
2026-06
×